Cargando…
Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study
BACKGROUND: Rising healthcare costs motivate continued cost-reduction efforts. To help lower costs associated with open-angle glaucoma (OAG), a prevalent, progressive disease with substantial direct and indirect costs, clinicians need to understand the cost-effectiveness of intraocular pressure (IOP...
Autores principales: | Feldman, Robert M, Cioffi, George A, Liebmann, Jeffrey M, Weinreb, Robert N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064281/ https://www.ncbi.nlm.nih.gov/pubmed/32184559 http://dx.doi.org/10.2147/OPTH.S236030 |
Ejemplares similares
-
Microglial exosomes in retinal neuroinflammation: focus in glaucoma
por: Aires, Inês Dinis, et al.
Publicado: (2021) -
Recent advances in pharmacotherapy of glaucoma
por: Gupta, S. K., et al.
Publicado: (2008) -
Structural Change Can Be Detected in Advanced-Glaucoma Eyes
por: Belghith, Akram, et al.
Publicado: (2016) -
Glaucoma Medication Preferences among Glaucoma Specialists in Mexico
por: Lazcano-Gomez, Gabriel, et al.
Publicado: (2017) -
Risk Assessment for Glaucoma
por: Weinreb, Robert N, et al.
Publicado: (2009)